Shifting the lines against central nervous system disorders

« A disruptive technology, which can be applied in the treatment of numerous conditions »

> Press releases

THERANEXUS raises approximately 2.2 million euros in a placement reserved to a category of persons 

11/07/2019
Dowload PDF File (615 Ko)

THERANEXUS announces the launch of a capital increase by private placement for a maximum amount of euro 4 million

10/07/2019
Download PDF File (284 Ko)

THERANEXUS reports cash position as of June 30th 2019

08/07/2019
Download PDF File (268 Ko)

Theranexus and Beyond Batten Disease Foundation (BBDF) announce agreement in
principle to develop and market Batten disease drug candidate BBDF 101

27/06/2019
Download PDF File (416 Ko)

THERANEXUS invited to join in the HealthTech Investor Days (HTDI) 24 & 25 June in Paris

20/06/2019
Download PDF File (363 Ko)

THERANEXUS announces the formation of its scientific Board

04/06/2019
Download PDF File (375 Ko)

THERANEXUS to present new data on neuron-glia interactions at two scientific events

23/05/2019
Download PDF File (380 Ko)

THERANEXUS announces issuance of Chinese patent covering its drug candidate THN102

24/04/2019
Download PDF File (381 Ko)

THERANEXUS provides 2018 full-year results and update on activities

17/04/2019
Download PDF File (416 Ko)

THERANEXUS announces research collaboration with IRISA using artificial intelligence technologies to enhance therapeutic targeting of neuroglial interactions

09/04/2019
Download PDF File (376 Ko)